Benitec Biopharma to Participate in Upcoming Conferences in March

Core Viewpoint - Benitec Biopharma Inc. is actively participating in several upcoming healthcare conferences to showcase its advancements in gene therapy and its proprietary "Silence and Replace" platform [1][2][3]. Group 1: Company Overview - Benitec Biopharma Inc. is a clinical-stage biotechnology company based in Hayward, California, focused on developing novel genetic medicines [4]. - The company utilizes a proprietary "Silence and Replace" DNA-directed RNA interference platform that combines RNA interference with gene therapy [4]. - Benitec is developing therapeutics targeting chronic and life-threatening conditions, including Oculopharyngeal Muscular Dystrophy (OPMD) [4]. Group 2: Upcoming Conferences - Benitec will present at the TD Cowen 45 Annual Health Care Conference on March 5, 2025, from 9:50 AM to 10:20 AM EST, with a format of presentation and 1x1 meetings [2]. - The company will also participate in the Leerink Partners Global Healthcare Conference on March 12, 2025, from 9:20 AM to 9:50 AM EST, featuring a fireside chat and 1x1 meetings [2]. - Additionally, Benitec will be involved in the 2025 Muscular Dystrophy Association Clinical & Scientific Conference, with a panel discussion on March 18, 2025, and a presentation on March 19, 2025 [3].